Viewing data from:

CLINDAMYCIN PALMITATE HYDROCHLORIDE

ANDA

CLINDAMYCIN PALMITATE HYDROCHLORIDE | A201821 | RISING PHARMA HOLDINGS INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$0.1343

per ml

Lowest NADAC/Unit

$0.1343

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
64980051110CLINDAMYCIN (PEDI) 75 MG/5 ML	$0.1343	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain5 active DMFs3 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

PHARMACIA AND UPJOHN CO LLCCLINDAMYCIN PALMITATE HYDROCHLORIDE USP KALAMAZOO

DMF 134121998

APITORIA PHARMA PRIVATE LTDCLINDAMYCIN PALMITATE HYDROCHLORIDE USP (NON-STERILE DRUG SUBSTANCE)

DMF 234362009

CHONGQING BIOCARE PHARMACEUTICAL LTDCLINDAMYCIN PALMITATE HYDROCHLORIDE USP, NON-STERILE, BULK DRUG

DMF 239742010

SCI PHARMTECH INCCLINDAMYCIN PALMITATE HYDROCHLORIDE

DMF 249172011

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDCLINDAMYCIN PALMITATE HYDROCHLORIDE (PROCESS B)

DMF 272762013

ZHEJIANG HISOAR PHARMACEUTICAL CO LTDInactiveCLINDAMYCIN PALMITATE HYDROCHLORIDE

DMF 218962008

LUPIN LTDInactiveCLINDAMYCIN PALMITATE HYDROCHLORIDE USP

DMF 231152009

MYLAN LABORATORIES LTDInactiveCLINDAMYCIN PALMITATE HYDROCHLORIDE USP

DMF 240182010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 75MG BASE/5ML

0 patents0 exclusivities▴

FOR SOLUTION;ORAL | Approved: Aug 28, 2012

No patent or exclusivity listings for this strength.